A detailed history of Xtx Topco LTD transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 41,466 shares of KRON stock, worth $39,392. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,466
Previous 49,911 16.92%
Holding current value
$39,392
Previous $61,000 32.79%
% of portfolio
0.0%
Previous 0.01%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.92 - $1.5 $7,769 - $12,667
-8,445 Reduced 16.92%
41,466 $41,000
Q2 2024

Aug 12, 2024

BUY
$0.73 - $1.38 $6,640 - $12,552
9,096 Added 22.29%
49,911 $61,000
Q1 2024

May 13, 2024

BUY
$1.02 - $1.3 $8,958 - $11,417
8,783 Added 27.42%
40,815 $53,000
Q4 2023

Feb 13, 2024

BUY
$0.75 - $1.49 $8,113 - $16,118
10,818 Added 50.99%
32,032 $40,000
Q3 2023

Nov 13, 2023

SELL
$1.23 - $2.25 $696 - $1,273
-566 Reduced 2.6%
21,214 $27,000
Q2 2023

Aug 14, 2023

BUY
$1.24 - $1.92 $27,007 - $41,817
21,780 New
21,780 $37,000
Q4 2022

Feb 14, 2023

SELL
$1.44 - $3.44 $108,675 - $259,613
-75,469 Reduced 74.98%
25,184 $40,000
Q3 2022

Nov 14, 2022

BUY
$3.35 - $5.55 $127,748 - $211,643
38,134 Added 61.0%
100,653 $337,000
Q2 2022

Aug 15, 2022

BUY
$3.12 - $7.52 $195,059 - $470,142
62,519 New
62,519 $228,000

Others Institutions Holding KRON

About Kronos Bio, Inc.


  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $53.9M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.